427
+4.40%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Japan Hospice Holdings
Its shares trade on Tokyo Stock Exchange under the ticker 7061.T. It has been listed since 28 March 2019. In the fiscal year to 31 December 2025, it reported revenue of ¥14.17bn and net income of ¥278.0m. At that date it held total assets of ¥18.92bn and shareholders' equity of ¥3.68bn.
Japan Hospice Holdings, Inc. operates as a holding company which provides care for patients with end-stage cancer and those with incurable diseases with the mission of the research and dissemination of home hospices. The company is headquartered in Chiyoda-Ku, Tokyo-To. The company went IPO on 2019-03-28. The home hospices provided by the Company operate in the form of the provision of hospice houses and the provision of home hospice services. In the provision of hospice houses, the hospice houses operated by the Company are rental housing that tenants are limited to end-stage cancer patients and intractable diseases. In the provision of home hospice services, the Company provides home visit nursing, nursing small-scale multifunctional in-home nursing care, home nursing care support offices, visiting nursing care, in-home care, 24 hours periodic patrol and occasional correspondence visiting nursing care service.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 28 Mar 2019
- Employees
- 778
- Website
- jhospice.co.jp ↗
Leadership
Pay as last reported
- Mr. Tadashi TakahashiPresident, Chief Executive Officer, Representative Director, since 2017
- Mr. Shinichiro KatoChief Financial Officer, Vice President, Director, since 2017
- Mr. Satoru ArakawaIndependent Director
- Ms. Keiko TamuraIndependent Director, since 2020
- Mr. Takayuki TomidaIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Provides care for end-stage cancer and incurable diseases with a focus on home hospices.
- Operates hospice houses as rental housing limited to end-stage cancer patients and intractable diseases.
- Offers a range of home hospice services including nursing care and 24-hour support.
Weaknesses
- Relies on a single sector (Health Care) for operations.
- Limited to specific patient groups (end-stage cancer and incurable diseases).
- Dependent on a single business model (home hospices).
Opportunities
- Expansion into new regions within Japan for hospice services.
- Potential for partnerships with healthcare providers to enhance service offerings.
- Growing demand for end-of-life care services in aging populations.
Threats
- Regulatory changes affecting healthcare services in Japan.
- Competition from other hospice care providers in the market.
- Economic downturns impacting healthcare spending and patient affordability.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.